Science Under Siege: How Geopolitics is Testing the Limits of Cuban Medicine

As the U.S. intensifies economic pressure, Cuba’s renowned healthcare and biotech sectors face unprecedented strain, leaving scientists and policymakers scrambling to sustain essential services.

In the quiet corridors of the Cuban Center for Neuroscience, Mitchell Valdes-Sosa spends his days managing a paradox: how to maintain world-class medical innovation while the equipment and resources required to sustain it are systematically choked off. As a key architect of the nation’s biotechnological strategy, Valdes-Sosa is at the front lines of what he describes as an aggressive U.S. campaign to dismantle Cuba’s primary source of foreign revenue—its medical exports.

For decades, the island has built its international reputation on the strength of its public health system and its ability to export medical expertise. However, the current policy from the United States has shifted from standard trade restrictions to what officials in Havana call a direct assault on human services. The strategy is clear: by pressuring other countries to reject Cuban medical missions, Washington is effectively attempting to starve the island of the hard currency it uses to keep its domestic hospitals stocked and operational.

The Pressure on Medical Missions

The diplomatic squeeze has been particularly felt by the Henry Reeve Brigades, the medical teams that have historically provided aid across 62 countries. The U.S. government has characterized these missions as "forced labour," a claim Havana vehemently rejects. Valdes-Sosa argues that the reality is far more pragmatic. For the doctors involved, these missions represent a significant professional and financial opportunity, with salaries that far outpace those available at home.

The strategy of the United States, according to the Cuban administration, is to threaten sanctions not just against countries that hire these doctors, but against the officials and their families involved in the negotiations. The result is a chilling effect that has forced several nations to buckle under the pressure, leaving behind gaps in healthcare for underserved populations that once relied on Cuban support.

Why it matters: The Bigger Picture

This standoff is more than a bilateral dispute; it serves as a case study in how global superpowers can weaponise economic policy against the soft power of smaller nations. When a country’s "crown jewels"—in this case, its biotech and public health sectors—are targeted, the collapse of health indicators becomes a distinct possibility.

The ripple effect is already visible. Across the island, factories are reporting frequent power cuts and critical resource shortages. For a nation that has long relied on scientific prowess to navigate economic isolation, the current climate suggests that the intersection of high-level research and basic survival is becoming increasingly difficult to bridge. The struggle now is not just about medical diplomacy, but about whether a state-led healthcare model can withstand a sustained, multifaceted campaign of economic strangulation.